Latest Period
Q4 2025
CUSIP: 92025Y103
Latest Period
Q4 2025
Institutions Reporting
19
Shares (Excl. Options)
5,196,705
Price
$8.82
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 19 institutions filings for Q4 2025.
What is CUSIP 92025Y103?
CUSIP 92025Y103 identifies VALN - Valneva SE - Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 92025Y103:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bpifrance Participations SA | 9.3% | -11% | $117,881,356 | -$5,386,803 | 19,074,653 | -4.4% | Caisse des depots et consignations | 05 May 2026 |
| Frazier Life Sciences Public Fund, L.P. | 3.6% | $42,515,409 | 6,879,516 | Frazier Life Sciences Public Fund, L.P. | 05 May 2026 |
As of 31 Dec 2025, 19 institutional investors reported holding 5,196,705 shares of Valneva SE - Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares (VALN). This represents 2.7% of the company’s total 191,097,667 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 473,737 | $2,960,565 | -$165,410 | $6.25 | 12 |
| 2025 Q4 | 5,196,705 | $45,834,921 | -$814,852 | $8.82 | 19 |
| 2025 Q3 | 5,273,605 | $64,337,981 | +$9,258,710 | $12.20 | 18 |
| 2025 Q2 | 4,521,059 | $25,597,436 | +$21,780,789 | $5.67 | 18 |
| 2025 Q1 | 663,174 | $4,449,900 | -$330,767 | $6.71 | 13 |
| 2024 Q4 | 719,324 | $3,161,338 | -$280,577 | $4.37 | 11 |
| 2024 Q3 | 717,704 | $4,353,921 | +$389,325 | $6.04 | 10 |
| 2024 Q2 | 653,454 | $4,731,213 | +$1,429,019 | $7.01 | 10 |
| 2024 Q1 | 450,722 | $3,598,865 | +$506,837 | $7.92 | 10 |
| 2023 Q4 | 386,967 | $3,982,170 | -$145,220 | $10.33 | 8 |
| 2023 Q3 | 397,381 | $4,687,616 | +$223,275 | $11.79 | 9 |
| 2023 Q2 | 378,252 | $5,554,111 | -$261,312 | $14.75 | 9 |
| 2023 Q1 | 403,434 | $4,109,411 | +$547 | $10.25 | 9 |
| 2022 Q4 | 403,399 | $5,160,724 | -$392,157 | $12.72 | 8 |
| 2022 Q3 | 434,089 | $4,364,020 | +$3,738,586 | $10.10 | 9 |
| 2022 Q2 | 61,902 | $1,402,540 | -$2,601,272 | $22.70 | 9 |
| 2022 Q1 | 137,856 | $4,704,860 | +$773,595 | $34.29 | 11 |
| 2021 Q4 | 115,354 | $6,431,102 | -$3,086,071 | $55.51 | 10 |
| 2021 Q3 | 263,396 | $8,270,280 | -$15,100,241 | $31.40 | 8 |
| 2021 Q2 | 800,882 | $21,104,000 | +$21,104,000 | $26.36 | 9 |